NASDAQ: KERX Investor Alert: Lawsuit Filed Against Acquisition by Keryx Biopharmaceuticals, Inc.
October 23, 2018 at 12:00 PM EDT
San Diego, CA -- (SBWIRE) -- 10/23/2018 -- An investor, who currently holds shares of Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), filed a lawsuit against the takeover of Keryx Biopharmaceuticals, Inc.
